Taro Pharmaceutical Indus TARO reported its Q3 earnings results on Thursday, January 27, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Taro Pharmaceutical Indus missed estimated earnings by 23.08%, reporting an EPS of $0.7 versus an estimate of $0.91, which surprised analysts.
Revenue was up $1.15 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.36, which was followed by a 7.14% drop in the share price the next day.
Here's a look at Taro Pharmaceutical Indus's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.02 | 0.84 | 0.92 | 1.01 |
| EPS Actual | 0.66 | 1.09 | 0.81 | 0.86 |
| Revenue Estimate | 153.23M | 137.23M | 147.33M | 152.63M |
| Revenue Actual | 131.99M | 147.11M | 148.35M | 140.15M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
